The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
BlackRock Sus Adg Intl Eq Ins BRZIX
- NAV / 1-Day Return 11.12 / +1.46 %
- Total Assets 15.3 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.500%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2.0 Mil
- Status Open
- TTM Yield 2.44%
- Turnover 118%
USD | NAV as of Apr 22, 2024 | 1-Day Return as of Apr 22, 2024, 10:15 PM GMT+0
Morningstar’s Analysis BRZIX
Will BRZIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 3.12 | 506,717 | Healthcare |
ASML Holding NV | 2.98 | 483,715 | Technology |
BlackRock Liquidity T-Fund Instl | 2.26 | 366,910 | Cash and Equivalents |
Nestle SA | 2.16 | 351,767 | Consumer Defensive |
AstraZeneca PLC | 1.95 | 317,396 | Healthcare |
SAP SE | 1.95 | 316,318 | Technology |
Novartis AG Registered Shares | 1.85 | 300,707 | Healthcare |
Shell PLC | 1.67 | 271,815 | Energy |
Siemens AG | 1.56 | 254,376 | Industrials |
Tokyo Electron Ltd | 1.44 | 233,467 | Technology |